Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Taldefgrobep

Taldefgrobep Alfa in Adults With Overweight and Obesity

Biohaven Therapeutics · Phase 2 · Active, not recruiting · Enrollment 150

NCT07281495

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Taldefgrobep Alpha once weeklyn/rn/rn/rn/r
Placebo once weeklyn/rn/rn/rn/r
Taldefgrobep Alpha once every 4 weeksn/rn/rn/rn/r
Placebo once every 4 weeksn/rn/rn/rn/r

Not shown

  • Taldefgrobep Alpha once weekly: endpoint not reported
  • Placebo once weekly: endpoint not reported
  • Taldefgrobep Alpha once every 4 weeks: endpoint not reported
  • Placebo once every 4 weeks: endpoint not reported